15:57 May 29

SMS Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
369.25
-8.10 (-2.15%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

SMS Pharmaceuticals Ltd. Financials

SMS Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
369.25
-8.10 (-2.15%)
15:57 May 29
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

38/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

10

Weakness

3

Opportunity

1

Threats

1

12.97 %

ROE %

7.48 %

ROA %

11.50

EPS

83.91

BVPS

11.49 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
519.87 522.05 709.26 782.75 886.87
Operating Expenses +
405.54 467.54 592.64 643.76 715.59
Raw Material
387.95 299.73 425.26 501.87 516.44
Increase Decrease in Cost
-112.5 36.08 -1 -64.81 -23.09
Other Manufacturing Expense
55.04 57.31 73.44 0 0
Employee Cost
51.02 55.04 64.15 80.08 87.96
Miscellaneous Expenses
24.03 19.38 30.79 126.62 134.28
Operating Profit
114.33 54.51 116.62 138.99 171.28
Other Income
5.2 4.89 4.46 6.22 8.35
Depreciation
32.15 32.13 31.52 34.34 39.92
Interest
18.88 21.92 23.46 18.54 23.08
Profit before tax and exceptio..
68.5 5.35 66.11 92.34 116.64
Exceptional Items
0 0 0 0 0
PBT
68.5 5.35 66.11 92.34 116.64
Provision for Taxation
0.62 1.46 16.91 24.94 28.64
Net Profit
67.88 3.88 49.2 67.4 88
NET Profit after MI
62.22 -7.06 49.83 69.14 101.99
EPS
7.35 -0.83 5.89 8.16 11.15
Operating Profit Margin (%)
21.99 10.44 16.44 17.76 19.31
Net Profit Margin (%)
11.97 -1.35 7.03 8.83 11.5

SMS Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: